For many small and medium-sized biopharmaceutical companies, staying on top of intersecting trends and payer-related data points is beyond the responsibility or expertise of any individual in a sales or marketing team. An integrated market access function can provide valuable support by thinking and behaving like a service provider, pulling together bespoke teams that analyze the reimbursement landscape and educate physician practices, so companies succeed at launch.
Further, working with market access experts from the study design stage will enable R&D teams to craft protocols that will translate into fruitful—and compliant—pre-approval discussions with payers. This approach lays a credible foundation for a launch plan and can ensure success across the product development lifecycle.
Download the white paper.
